Renin-angiotensin system antagonists, glomerular filtration rate and blood pressure
Journal Title: Нирки - Year 2018, Vol 7, Issue 1
Abstract
The article deals with the mModern data on the influence of renin-angiotensin system blockers on the glomerular filtration rate, the level of arterial pressure and the outcome of chronic kidney disease. The strategy of rennin-angiotensine blockade is offered to be changed depending on the criteria values of glomerular filtration rate: a combination of inhibitors of angiotensin-converting enzyme + angiotensin receptors blockers, monotherapy and drug withdrawal in glomerular filtration rate under 15–30 ml/min/m2. The formula BRIMONEL for treatment of chronic kidney disease is given.
Authors and Affiliations
D. D. Ivanov
Keywords
Related Articles
- EP ID EP265052
- DOI 10.22141/2307-1257.7.1.2018.122214
- Views 103
- Downloads 0
Kidney damage associated with anti-phospholipid syndrome
Antiphospholipid syndrome (APS) is a common autoimmune disease caused by pathogenic antiphospholipid antibodies, leading to recurrent thrombosis and/or obstetric complications. It is important for nephrologists to know t...
Acetate-free Biofiltration for the Prevention of Intradialytic Hypеrcapnia in a Patient with Limited Pulmonary Reserve
A case of acute hypercapnia occurring during a session of bicarbonate hemodialysis is reported. The 82-year old female patient was affected by cardiac insufficiency, pulmonary hypertension and chronic obstructive lung d...
Features of renal involvement in systemic connective tissue diseases
Connective tissue diseases (CTDs) are a heterogeneous group of disorders that have certain clinical presentations and a disturbed immunoregulation, leading to autoantibody production. Subclinical or overt renal manifesta...
Hyperuricemia — an independent factor for the progression of chronic kidney disease
Objective of the research — to evaluate the efficacy of combined hypouricemic therapy in patients with hyperuricemia, urate nephropathy on the background of concomitant pathology (type 2 diabetes mellitus, hypertension)...
Algorithm for choosing hypoglycemic agents in patients with a diagnosis of atherosclerotic cardiovascular disease, heart failure or chronic kidney disease
.